Stefano Cereda

2.1k total citations
53 papers, 1.5k citations indexed

About

Stefano Cereda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Stefano Cereda has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Stefano Cereda's work include Pancreatic and Hepatic Oncology Research (39 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Neuroendocrine Tumor Research Advances (14 papers). Stefano Cereda is often cited by papers focused on Pancreatic and Hepatic Oncology Research (39 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Neuroendocrine Tumor Research Advances (14 papers). Stefano Cereda collaborates with scholars based in Italy, Switzerland and Malaysia. Stefano Cereda's co-authors include Michele Reni, Gianpaolo Balzano, Paolo Passoni, Carmen Belli, Roberto Nicoletti, Giuseppe Aprile, Eugenio Villa, Alessia Rognone, Valerio Di Carlo and Clara Fugazza and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Stefano Cereda

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefano Cereda Italy	21	1.1k	564	535	323	313	53	1.5k
Elide Matano Italy	14	907 0.9×	260 0.5×	863 1.6×	161 0.5×	228 0.7×	48	1.5k
Giuseppe Fornarini Italy	22	597 0.6×	305 0.5×	562 1.1×	166 0.5×	245 0.8×	125	1.3k
L. Roll Germany	4	1.7k 1.6×	736 1.3×	650 1.2×	530 1.6×	203 0.6×	8	1.9k
Laura Visa Spain	15	662 0.6×	262 0.5×	417 0.8×	334 1.0×	180 0.6×	37	1.0k
Florian Eisner Austria	10	989 0.9×	260 0.5×	409 0.8×	806 2.5×	334 1.1×	23	1.5k
Jörg Fahlke Germany	9	1.3k 1.2×	732 1.3×	650 1.2×	421 1.3×	120 0.4×	21	1.6k
Federica Cuppone Italy	20	1.1k 1.1×	111 0.2×	604 1.1×	388 1.2×	199 0.6×	50	1.5k
Enrique González‐Billalabeitia Spain	19	580 0.5×	154 0.3×	365 0.7×	399 1.2×	527 1.7×	75	1.3k
Tracy Proverbs‐Singh United States	7	688 0.6×	116 0.2×	268 0.5×	75 0.2×	210 0.7×	14	1.1k
Joel Baumgartner United States	19	360 0.3×	567 1.0×	290 0.5×	179 0.6×	87 0.3×	56	1.1k

Countries citing papers authored by Stefano Cereda

Since Specialization

Citations

This map shows the geographic impact of Stefano Cereda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Cereda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Cereda more than expected).

Fields of papers citing papers by Stefano Cereda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Cereda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Cereda. The network helps show where Stefano Cereda may publish in the future.

Co-authorship network of co-authors of Stefano Cereda

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Cereda. A scholar is included among the top collaborators of Stefano Cereda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Cereda. Stefano Cereda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vitiello, Francesco, Stefano Cereda, Silvia Foti, et al.. (2023). Immunotherapy in small bowel adenocarcinoma: a potential role?. Immunological Medicine. 47(1). 1–5. 3 indexed citations

Peraldo‐Neia, Caterina, Giuliana Cavalloni, Elisabetta Fenocchio, et al.. (2018). Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. PLoS ONE. 13(1). e0191593–e0191593. 13 indexed citations

Venturini, Massimo, Claudio Sallemi, Giulia Agostini, et al.. (2016). Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study. British Journal of Radiology. 89(1067). 20160247–20160247. 15 indexed citations

Reni, Michele, Erica Dugnani, Stefano Cereda, et al.. (2015). (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial. Clinical Cancer Research. 22(5). 1076–1085. 140 indexed citations

Brandi, Giovanni, Michela Venturi, Maria A. Pantaleo, et al.. (2015). Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. Digestive and Liver Disease. 48(3). 231–241. 67 indexed citations

Vasile, Enrico, Giovanni Brandi, Francesco Leone, et al.. (2015). P-115 Transarterial Chemo-Embolization (TACE) and Radio-Embolization (TARE) in the combined modality treatment of advanced biliary tract cancer (aBTC): evaluation of feasibility and activity. Annals of Oncology. 26. iv32–iv32. 1 indexed citations

Fornaro, Lorenzo, Caterina Vivaldi, Stefano Cereda, et al.. (2015). Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data. Journal of Experimental & Clinical Cancer Research. 34(1). 156–156. 49 indexed citations

Passoni, Paolo, Michele Reni, Giovanni Mauro Cattaneo, et al.. (2013). Hypofractionated Image-Guided IMRT in Advanced Pancreatic Cancer With Simultaneous Integrated Boost to Infiltrated Vessels Concomitant With Capecitabine: A Phase I Study. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1000–1006. 23 indexed citations

Cereda, Stefano, Carmen Belli, Alessia Rognone, Elena Mazza, & Michele Reni. (2013). Second-line therapy in advanced biliary tract cancer: What should be the standard?. Critical Reviews in Oncology/Hematology. 88(2). 368–374. 16 indexed citations

10.

Cattaneo, Giovanni Mauro, Paolo Passoni, B. Longobardi, et al.. (2013). Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma. Radiotherapy and Oncology. 108(1). 66–71. 30 indexed citations

11.

Arcidiacono, Paolo Giorgio, Silvia Carrara, Michele Reni, et al.. (2012). Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointestinal Endoscopy. 76(6). 1142–1151. 121 indexed citations

12.

Belli, Carmen, Stefano Cereda, Santosh Anand, & Michele Reni. (2012). Neoadjuvant therapy in resectable pancreatic cancer: A critical review. Cancer Treatment Reviews. 39(5). 518–524. 36 indexed citations

13.

Pecorelli, Nicolò, Marco Braga, Claudio Doglioni, et al.. (2012). Preoperative Chemotherapy Does Not Adversely Affect Pancreatic Structure and Short-Term Outcome after Pancreatectomy. Journal of Gastrointestinal Surgery. 17(3). 488–493. 18 indexed citations

14.

Cereda, Stefano, Michele Reni, Alessia Rognone, et al.. (2011). Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial. Chemotherapy. 57(2). 156–161. 13 indexed citations

15.

Cereda, Stefano, Alessia Rognone, Elena Mazza, et al.. (2009). Weekly Epirubicin as Salvage Therapy in Patients with Gemcitabine-Resistant Advanced Pancreatic Cancers. Journal of Chemotherapy. 21(6). 698–700. 2 indexed citations

16.

Reni, Michele, Stefano Cereda, Elena Mazza, et al.. (2008). PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen as Second-Line Therapy in Patients With Progressive or Recurrent Pancreatic Cancer After Gemcitabine-Containing Chemotherapy. American Journal of Clinical Oncology. 31(2). 145–150. 20 indexed citations

17.

Mandalà, Mario, Michele Reni, Stefano Cascinu, et al.. (2007). Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients. Annals of Oncology. 18(10). 1660–1665. 113 indexed citations

18.

Meazza, Cristina, Andrea Ferrari, Michela Casanova, et al.. (2006). Rhabdomyosarcoma of the Head and Neck Region: Experience at the Pediatric Unit of the Istituto Nazionale Tumori, Milan. The Journal of Otolaryngology. 35(1). 53–53. 15 indexed citations

19.

Terenziani, Monica, Filippo Spreafico, Paola Collini, et al.. (2004). Adult Wilms' tumor: A monoinstitutional experience and a review of the literature. Cancer. 101(2). 289–293. 58 indexed citations

20.

Cereda, Stefano, Graziella Cefalo, Monica Terenziani, Serena Catania, & Franca Fossati‐Bellani. (2003). Becker Muscular Dystrophy in a Patient With Hodgkin's Disease. Journal of Pediatric Hematology/Oncology. 26(1). 72–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact